Skip to main content
. 2015 Oct 27;10(10):e0141365. doi: 10.1371/journal.pone.0141365

Fig 7. Effects of pathway inhibition on CArG-RE and ACTA2-Pr activity and αSMA protein levels.

Fig 7

Response of (A) CArG-RE and (B) ACTA2-Pr on day 7 of differentiation in the presence of the indicated inhibitors. (C) Western blot for αSMA on day 7 of differentiation in the presence of the indicated inhibitors. GAPDH served as loading control. (D) Relative expression of αSMA as determined from the band intensities in (C). Normalized intensities were scaled to the intensity in DM without inhibitors. * denotes statistical significance (p<0.05, n = 3) as compared to DM.